Topical Botulinum Toxin Delivery via Charged Polymeric Carrier
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering botulinum toxin are invasive, requiring injections that can be painful and limited in application area, with high doses needed for therapeutic effects, whereas a topical, transdermal delivery method would provide a safer, more efficient, and aesthetically desirable alternative for various therapeutic and cosmetic purposes.
Innovation Solution
A composition comprising botulinum toxin associated non-covalently with a carrier having a polymeric backbone with positively charged branching groups, such as -(gly)n1-(arg)n2, HIV-TAT, or Antennapedia PTD, enables transdermal delivery by topical application, allowing for muscle paralysis, reducing hypersecretion, and providing cosmetic benefits without the need for injections.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If botulinum toxin is delivered via injection, then therapeutic effects are achieved, but the method is invasive, painful, and limited in application area
Solution Approach 1:
The patent uses a carrier molecule as an intermediary to facilitate transdermal delivery of botulinum toxin. The carrier has a polymeric backbone with positively charged branching groups that enable the toxin to penetrate intact skin without injection, thereby eliminating invasiveness and pain while maintaining therapeutic delivery capability
Solution Approach 2:
The patent modifies the physical and chemical parameters of the botulinum toxin delivery system by associating it with a carrier having specific properties (polymeric backbone, positively charged branching groups). This parameter change enables the toxin to cross the skin barrier through topical application rather than requiring injection
2Reliability
If high doses of botulinum toxin are used for therapeutic effects, then efficacy is improved, but toxicity increases
Solution Approach 1:
The carrier acts as a mediator that enables efficient transdermal transport of the toxin, allowing for lower dosages to achieve therapeutic effects. The carrier-facilitated delivery system improves bioavailability and reduces the amount of toxin needed, thereby maintaining efficacy while reducing toxicity
Solution Approach 2:
The patent changes the delivery parameters by using a topical formulation with a specialized carrier, which alters the pharmacokinetics of botulinum toxin. This enables achieving therapeutic concentrations at the target site with lower overall doses, reducing systemic toxicity
3Ease of operation
If botulinum toxin is associated non-covalently with a carrier having positively charged branching groups, then transdermal delivery is enabled, but the composition complexity increases
Solution Approach 1:
The patent introduces a carrier molecule as an intermediary component with a polymeric backbone and positively charged branching groups. This carrier simplifies the delivery process by enabling transdermal penetration through non-covalent association with the toxin, making topical application feasible despite the added compositional element
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The described method allows for effective transdermal delivery of botulinum toxin across intact skin, achieving significant muscle paralysis and cosmetic effects, including wrinkle reduction and hyperhidrosis treatment, with reduced toxicity and dosage, as demonstrated in both animal and human studies.
Implementation Method 1
a botulinum toxin present in an effective amount for transdermal delivery thereof, and a carrier that has a polymeric backbone with attached positively charged branching groups. The association between the carrier and the botulinum toxin is non-covalent
Implementation Method 2
enables the transport or delivery of a botulinum toxin through the skin or epithelium (also referred to as 'transdermal delivery')
Data Source
AI summary
A composition for topical application of a botulinum toxin (including botulinum toxin derivatives) comprises a botulinum toxin and a carrier comprising a polymeric backbone comprising a long-chain polypeptide or nonpeptidyl polymer having attached positively charged branching or “efficiency” groups. The invention also relates to methods for reducing muscle paralysis and other conditions that may be treated with a botulinum toxin, particularly paralysis of subcutaneous, and most particularly, facial, muscles, by topically applying an effective amount of the botulinum toxin and carrier, in conjunction, to the subject's skin or epithelium. Kits for administration are also described.